By: Jeffery Bigongiari
The grant series will be used for a spectrum of activities related to the production of vaccine, including infrastructure development, training on vaccine manufacturing and the development and distribution of vaccine technology, according to BusinessWire.com.
“Diseases do not respect borders so increasing the ability to make flu vaccine in any country helps every country reduce the spread of flu,” Robin Robinson, BARDA’s director, told BusinessWire.com. “While we continue to build vaccine manufacturing capacity in the United States, and develop new, faster technologies for producing vaccine domestically, we can increase pandemic preparedness worldwide by helping other countries take advantage of technology.”
Leave a Reply